Published in Sabouraudia on June 01, 1965
Gingival flora of the dog with special reference to bacteria associated with bites. J Clin Microbiol (1976) 1.84
Predominant cultivable flora isolated from human root surface caries plaque. Infect Immun (1975) 1.43
Morphological, biochemical, and serological studies on 64 strains of Actinomyces israelii. J Bacteriol (1969) 1.34
Method for preclinical evaluation of antiplaque agents. Antimicrob Agents Chemother (1972) 1.25
In vitro evaluation of three iodine-containing compounds as antiplaque agents. Antimicrob Agents Chemother (1977) 1.23
Differential medium for detecting dental plaque bacteria resembling Actinomyces viscosus and Actinomyces naeslundii. J Clin Microbiol (1975) 1.22
In vitro evaluation of seven cationic detergents as antiplaque agents. Antimicrob Agents Chemother (1979) 1.17
Structural requirements of guanide, biguanide, and bisbiguanide agents for antiplaque activity. Antimicrob Agents Chemother (1977) 1.13
Actinomyces and related organisms in human infections. Clin Microbiol Rev (2015) 1.06
Extracellular polysaccharides of Actinomyces viscosus. Infect Immun (1974) 1.06
Toxic properties of the cell wall of gram-positive bacteria. J Bacteriol (1967) 0.98
In vitro antiplaque activity of octenidine dihydrochloride (WIN 41464-2) against preformed plaques of selected oral plaque-forming microorganisms. Antimicrob Agents Chemother (1983) 0.95
Polyphosphate inhibition of growth of plaques formed by streptococci and diphtheroids implicated in oral disease. Infect Immun (1970) 0.95
In vitro plaque formation by several oral diphtheroids implicated in periodontal disease. Infect Immun (1970) 0.88
Isolation of Actinomyces viscosus from two patients with clinical infections. J Clin Pathol (1977) 0.85
Relationship between structure and antiplaque and antimicrobial activities for a series of bispyridines. Antimicrob Agents Chemother (1983) 0.82
Identification of Actinomyces viscosus from canine infections. J Clin Microbiol (1975) 0.75
Development of a chemically defined liquid medium for growth of Legionella pneumophila. J Clin Microbiol (1979) 6.10
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
A selective medium for Streptococcus mutans. Arch Oral Biol (1973) 5.41
Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res (1997) 4.22
A case of phaeohyphomycosis caused by a new species of Phialophora. Mycologia (1974) 3.48
An in vitro method for assessing the plaque forming ability of oral bacteria. Arch Oral Biol (1967) 3.11
Periodontal lesions in hamsters and gnotobiotic rats infected with actinomyces of human origin. J Periodontal Res (1972) 3.10
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet (2004) 3.10
The prevalence of enterococci in the human mouth and their pathogenicity in animal models. Arch Oral Biol (1975) 2.98
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol (2006) 2.94
A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer (1984) 2.89
Amino acid requirements of Legionella pneumophila. J Clin Microbiol (1980) 2.88
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br J Cancer (2004) 2.87
The occurrence of certain "caries-inducing" streptococci in human dental plaque material with special reference to frequency and activity of caries. Arch Oral Biol (1968) 2.59
Familial breast cancer. BMJ (1994) 2.54
Uptake of screening and prevention in women at very high risk of breast cancer. Lancet (2001) 2.45
Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J Clin Oncol (1997) 2.39
Production of superoxide and hydrogen peroxide in medium used to culture Legionella pneumophila: catalytic decomposition by charcoal. Appl Environ Microbiol (1983) 2.34
Perception of risk in women with a family history of breast cancer. Br J Cancer (1993) 2.32
The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology (1995) 2.27
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet (2003) 2.24
A method of sampling human dental plaque for certain "caries-inducing" streptococci. Arch Oral Biol (1968) 2.17
Metal requirements of Legionella pneumophila. J Clin Microbiol (1981) 2.12
Filamentous bacteria isolated from human root surface caries. Arch Oral Biol (1972) 2.11
High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy. Breast Cancer Res Treat (2001) 1.88
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat (1999) 1.84
Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer (1991) 1.83
Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years. Br J Cancer (2007) 1.80
Identification of Actinomyces israelii and Actinomyces naeslundii by fluorescent-antibody and agar-gel diffusion techniques. J Bacteriol (1967) 1.80
Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab (1997) 1.79
Absence of siderophore activity in Legionella species grown in iron-deficient media. J Bacteriol (1983) 1.77
Laboratory identification of Rothia dentocariosa and its occurrence in human clinical materials. Appl Microbiol (1969) 1.77
The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer (1994) 1.75
The early establishment of Streptococcus mutans in the mouths of infants. Arch Oral Biol (1975) 1.74
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer (2001) 1.70
Treatment of advanced prostatic cancer with LHRH analogue ICI 118630: clinical response and hormonal mechanisms. Lancet (1983) 1.69
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer. Eur J Cancer (1996) 1.67
Factors from saliva and oral bacteria, chemotactic for polymorphonuclear leukocytes: their possible role in gingival inflammation. J Periodontol (1970) 1.66
The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer (1989) 1.65
In vitro methods for the study of plaque formation and carious lesions. Arch Oral Biol (1966) 1.61
The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas. Int J Cancer (1984) 1.61
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond) (2010) 1.61
Microsporum gypseum and Histoplasma capsulatum Spores in Soil and Water. Science (1952) 1.59
Development of a selective medium for detection and enumeration of Actinomyces viscosus and Actinomyces naeslundii in dental plaque. J Clin Microbiol (1982) 1.58
Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast. J Natl Cancer Inst (1997) 1.58
Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol (2007) 1.57
Purification, composition, and serological characterization of histoplasmin-H and M antigens. Infect Immun (1974) 1.57
Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet (1984) 1.56
Comparative cell wall analyses of morphological forms within the genus Actinomyces. J Bacteriol (1967) 1.56
Rapid method for characterization of actinomycetes by cell wall composition. Appl Microbiol (1968) 1.54
Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia (1998) 1.52
A filamentous microorganism isolated from periodontal plaque in hamsters. 1. Isolation, morphology and general cultural characteristics. Sabouraudia (1963) 1.52
Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J Pathol (1996) 1.49
Determination and analysis of Actinomyces israelii serotypes by fluorescent-antibody procedures. J Bacteriol (1969) 1.49
Can hair be used to screen for breast cancer? J Med Genet (2000) 1.49
Growth of Histoplasma capsulatum. VI. Maintenance of the mycelial phase. Appl Microbiol (1970) 1.46
A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Ther (2000) 1.45
Neuropathic joints. Semin Arthritis Rheum (1972) 1.44
Screening by mammography, women with a family history of breast cancer. Eur J Cancer (1998) 1.44
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol (1996) 1.44
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. Cancer J Sci Am (2006) 1.43
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer Res (1994) 1.43
Nonhemolytic Listeria monocytogenes mutants that are also noninvasive for mammalian cells in culture: evidence for coordinate regulation of virulence. Infect Immun (1990) 1.43
Factors influencing the production of H and M antigens by Histoplasma capsulatum: development and evaluation of a shake culture. Appl Microbiol (1972) 1.43
Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations. Clin Endocrinol (Oxf) (1994) 1.42
Role of sucrose in colonization of Streptococcus mutans in conventional Sprague-Dawley rats. J Dent Res (1976) 1.42
The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast. Br J Cancer (1988) 1.42
Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab (1999) 1.42
Characterization of bacteria isolated from human root surface carious lesions. J Dent Res (1974) 1.42
Plaque formation and periodontal pathology in gnotobiotic rats infected with an oral actinomycete. Am J Pathol (1965) 1.42
Effect of thimerosal on the whole yeast phase antigen of Histoplasma capsulatum. Mycopathol Mycol Appl (1969) 1.41
An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole. Eur J Cancer (2004) 1.39
Effect of clothing on dispersal of Staphylococcus aureus by males and females. Lancet (1974) 1.39
The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci U S A (1989) 1.38
Actinomyces naeslundii as an agent of human actinomycosis. Appl Microbiol (1969) 1.37
Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer (1993) 1.36
Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet (1983) 1.35
A filamentous microorganism isolated from periodontal plaque in hamsters. II. Physiological and biochemical characteristics. Sabouraudia (1963) 1.34
Path of glucose breakdown and cell yields of a facultative anaerobe, Actinomyces naeslundii. J Gen Microbiol (1967) 1.34
Potentially cariogenic streptococci in selected population groups in the western hemisphere. J Am Dent Assoc (1969) 1.33
Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psychooncology (1999) 1.32
Mechanism of action of adjuvant chemotherapy in early breast cancer. Lancet (1986) 1.30
Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet (2001) 1.28
Cancer experience in the relatives of an unselected series of breast cancer patients. Br J Cancer (1994) 1.28
Carcinomatous meningitis in solid tumours. Ann Oncol (1996) 1.27
Histological detection of oestrogen receptor in human breast carcinomas. Lancet (1980) 1.26
Actinomycosis caused by Arachnia propionica: report of 11 cases. Am J Clin Pathol (1973) 1.26
A comparison of three assays used for the in vitro chemosensitivity testing of human tumours. Br J Cancer (1984) 1.25
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial. J Clin Oncol (1990) 1.25
Observations on the implantation and transmission of Streptococcus mutans in humans. J Dent Res (1972) 1.25
Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr Relat Cancer (2006) 1.24
Demonstration of Actinomyces and Arachnia species in cervicovaginal smears by direct staining with species-specific fluorescent-antibody conjugate. J Clin Microbiol (1981) 1.24
Preparation and description of high-molecular-weight soluble surface antigens from a group A Streptococcus. J Bacteriol (1968) 1.24
Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer. J Med Genet (2011) 1.23
Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma. BMJ (1988) 1.23